191 related articles for article (PubMed ID: 18021376)
1. Concurrent gain of 17q and the MYC oncogene in a medullomyoblastoma.
Lindberg E; Persson A; Øra I; Mertens F; Englund E; Gisselsson D
Neuropathology; 2007 Dec; 27(6):556-60. PubMed ID: 18021376
[TBL] [Abstract][Full Text] [Related]
2. Isochromosome 17q, MYC amplification and large cell/anaplastic phenotype in a case of medullomyoblastoma with extracranial metastases.
Wright KD; von der Embse K; Coleman J; Patay Z; Ellison DW; Gajjar A
Pediatr Blood Cancer; 2012 Sep; 59(3):561-4. PubMed ID: 22147345
[TBL] [Abstract][Full Text] [Related]
3. Cytogenetic evaluation of isochromosome 17q in posterior fossa tumors of children and correlation with clinical outcome in medulloblastoma. Detection of a novel chromosomal abnormality.
DeChiara C; Borghese A; Fiorillo A; Genesio R; Conti A; D'Amore R; Pettinato G; Varone A; Maggi G
Childs Nerv Syst; 2002 Aug; 18(8):380-4. PubMed ID: 12192498
[TBL] [Abstract][Full Text] [Related]
4. Medullomyoblastoma: a radiographic and clinicopathologic analysis of six cases and review of the literature.
Helton KJ; Fouladi M; Boop FA; Perry A; Dalton J; Kun L; Fuller C
Cancer; 2004 Sep; 101(6):1445-54. PubMed ID: 15368333
[TBL] [Abstract][Full Text] [Related]
5. Outcome prediction in pediatric medulloblastoma based on DNA copy-number aberrations of chromosomes 6q and 17q and the MYC and MYCN loci.
Pfister S; Remke M; Benner A; Mendrzyk F; Toedt G; Felsberg J; Wittmann A; Devens F; Gerber NU; Joos S; Kulozik A; Reifenberger G; Rutkowski S; Wiestler OD; Radlwimmer B; Scheurlen W; Lichter P; Korshunov A
J Clin Oncol; 2009 Apr; 27(10):1627-36. PubMed ID: 19255330
[TBL] [Abstract][Full Text] [Related]
6. Large-cell medulloblastomas. A distinct variant with highly aggressive behavior.
Giangaspero F; Rigobello L; Badiali M; Loda M; Andreini L; Basso G; Zorzi F; Montaldi A
Am J Surg Pathol; 1992 Jul; 16(7):687-93. PubMed ID: 1530108
[TBL] [Abstract][Full Text] [Related]
7. Molecular cytogenetic analysis of medulloblastomas and supratentorial primitive neuroectodermal tumors by using conventional banding, comparative genomic hybridization, and spectral karyotyping.
Bayani J; Zielenska M; Marrano P; Kwan Ng Y; Taylor MD; Jay V; Rutka JT; Squire JA
J Neurosurg; 2000 Sep; 93(3):437-48. PubMed ID: 10969942
[TBL] [Abstract][Full Text] [Related]
8. Detection of genetic and chromosomal aberrations in medulloblastomas and primitive neuroectodermal tumors with DNA microarrays.
Kagawa N; Maruno M; Suzuki T; Hashiba T; Hashimoto N; Izumoto S; Yoshimine T
Brain Tumor Pathol; 2006 Apr; 23(1):41-7. PubMed ID: 18095118
[TBL] [Abstract][Full Text] [Related]
9. Isochromosome 17q is a negative prognostic factor in poor-risk childhood medulloblastoma patients.
Pan E; Pellarin M; Holmes E; Smirnov I; Misra A; Eberhart CG; Burger PC; Biegel JA; Feuerstein BG
Clin Cancer Res; 2005 Jul; 11(13):4733-40. PubMed ID: 16000568
[TBL] [Abstract][Full Text] [Related]
10. Derivative (22)t(3;22)(q12;p11.1) in desmoplastic medulloblastoma.
Manor E; Bodner L; Kachko P; Kapelushnik J
Cancer Genet Cytogenet; 2010 Jan; 196(2):175-8. PubMed ID: 20082855
[TBL] [Abstract][Full Text] [Related]
11. No preferential parent of origin for the isochromosome 17q in childhood primitive neuroectodermal tumor (medulloblastoma).
Biegel JA; Wentz E
Genes Chromosomes Cancer; 1997 Feb; 18(2):143-6. PubMed ID: 9115964
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive molecular cytogenetic investigation of chromosomal abnormalities in human medulloblastoma cell lines and xenograft.
Aldosari N; Wiltshire RN; Dutra A; Schrock E; McLendon RE; Friedman HS; Bigner DD; Bigner SH
Neuro Oncol; 2002 Apr; 4(2):75-85. PubMed ID: 11916498
[TBL] [Abstract][Full Text] [Related]
13. Clinical and molecular stratification of disease risk in medulloblastoma.
Gilbertson R; Wickramasinghe C; Hernan R; Balaji V; Hunt D; Jones-Wallace D; Crolla J; Perry R; Lunec J; Pearson A; Ellison D
Br J Cancer; 2001 Sep; 85(5):705-12. PubMed ID: 11531256
[TBL] [Abstract][Full Text] [Related]
14. Medullomyoblastoma: a case report and literature review of a rare tumor entity.
Smolle E; Al-Qubati S; Stefanits H; Haberler C; Kleinert R; Haybaeck J
Anticancer Res; 2012 Nov; 32(11):4939-44. PubMed ID: 23155263
[TBL] [Abstract][Full Text] [Related]
15. Karyotypic evolution pathways in medulloblastoma/primitive neuroectodermal tumor determined with a combination of spectral karyotyping, G-banding, and fluorescence in situ hybridization.
Cohen N; Betts DR; Tavori U; Toren A; Ram T; Constantini S; Grotzer MA; Amariglio N; Rechavi G; Trakhtenbrot L
Cancer Genet Cytogenet; 2004 Feb; 149(1):44-52. PubMed ID: 15104282
[TBL] [Abstract][Full Text] [Related]
16. Correlation of chromosome 17p loss with clinical outcome in medulloblastoma.
Emadian SM; McDonald JD; Gerken SC; Fults D
Clin Cancer Res; 1996 Sep; 2(9):1559-64. PubMed ID: 9816333
[TBL] [Abstract][Full Text] [Related]
17. Medullomyoblastoma with calcification: a case report.
Chaturvedi S; Gupta S; Singhal S; Kumari R
Neuropathology; 2008 Feb; 28(1):93-7. PubMed ID: 18181837
[TBL] [Abstract][Full Text] [Related]
18. Gene aberrations in childhood brain tumors.
Kucerová H; Stejskalová E; Vícha A; Tichý M; Chánová M; Sumerauer D; Koutechký J; Eckschlager T
Folia Biol (Praha); 2000; 46(5):187-90. PubMed ID: 11055797
[TBL] [Abstract][Full Text] [Related]
19. Characterization of chromosome 17 abnormalities in medulloblastomas.
Aldosari N; Rasheed BK; McLendon RE; Friedman HS; Bigner DD; Bigner SH
Acta Neuropathol; 2000 Apr; 99(4):345-51. PubMed ID: 10787031
[TBL] [Abstract][Full Text] [Related]
20. Role of LIM and SH3 protein 1 (LASP1) in the metastatic dissemination of medulloblastoma.
Traenka C; Remke M; Korshunov A; Bender S; Hielscher T; Northcott PA; Witt H; Ryzhova M; Felsberg J; Benner A; Riester S; Scheurlen W; Grunewald TG; von Deimling A; Kulozik AE; Reifenberger G; Taylor MD; Lichter P; Butt E; Pfister SM
Cancer Res; 2010 Oct; 70(20):8003-14. PubMed ID: 20924110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]